Persist AI specializes in building and optimizing long-acting injectable formulations, offering high-throughput formulation screening, automated drug release testing, method transfer and manufacturing scale-up. This helps drug manufacturers solve problems with drug clearance in the body, formulation instability, acute toxicity, shelf life and many other drug formulation related problems.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
08/04/23 | $4,000,000 |
2048 Ventures![]() Fellows Fund InnoSpark Ventures Pioneer Fund Y Combinator | undisclosed | |
05/19/25 | $12,000,000 | Series A |
2048 Ventures Asymmetry Ventures Cartography Capital Eli Lilly and Company Ford Street Ventures Goldman Sachs Good AI Capital InnoSpark Ventures MBX Capital Purdue Strategic Ventures Shimadzu Future Innovation Fund Signal Fire Spero Ventures ![]() YCombinator | undisclosed |